Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Research Scholarships - Master's program

University of Toronto

$27,000.00

Investigating the effects on the gut microbiome on glioblastoma initiation and progression

EF 2025-26

Résumé
Glioblastoma (GBM) is one of the most common and aggressive forms of primary brain cancer, accounting for 14.2% of all brain tumours. Standard treatment for GBM largely comprises palliative care, such as surgery and chemoradiotherapy. Bettering our understanding of how GBM initiates and develops will allow us to develop more effective therapies through novel approaches. We are interested in the role of the gut-brain axis (GBA) in brain tumour development, defined as the reciprocal communication pathway between the central nervous system (CNS) and the gastrointestinal tract. Digestive products of the gut microbiome, microorganisms that colonize the gut, are able to influence brain function and its immune environment as circulating factors that can cross the blood-brain barrier. Particularly, short-chain fatty acids (SCFAs) have been linked to the activation of microglia, immune cells present in the brain. The role of these factors in GBM tumour initiation remains unknown, but the prevalence of inflammation in GBM implicates their potential for promoting tumour progression through immune cell populations. The first aim of this project is to define the effects of the gut microbiome on GBM tumour initiation using mouse models. Subsequently, we will interrogate the effect of specific factors produced by the gut microbiome, such as SCFAs, on human GBM stem cell cultures to determine their influence on driving cancer formation. As GBM research is largely focused on factors of the CNS, we are aiming to provide a fresh perspective on brain cancer biology by studying the GBA. Ascertaining the link between the gut and brain tumour development will open up new avenues for therapeutic interventions that target the gut microbiome.
Programme
Master's Award: Canada Graduate Research Scholarships - Master's program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
572617
Name
Liao Kaixi C
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the effects on the gut microbiome on glioblastoma initiation and progression
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Cancer Initation; Cancer Stem Cell; Germ-Free; Glioblastoma; Gut-Brain Axis; High-Grade Glioma; Microglia; Neuroinflammation; Short-Chain Fatty Acids; Single-Cell Rna Sequencing
Abstract
Glioblastoma (GBM) is one of the most common and aggressive forms of primary brain cancer, accounting for 14.2% of all brain tumours. Standard treatment for GBM largely comprises palliative care, such as surgery and chemoradiotherapy. Bettering our understanding of how GBM initiates and develops will allow us to develop more effective therapies through novel approaches. We are interested in the role of the gut-brain axis (GBA) in brain tumour development, defined as the reciprocal communication pathway between the central nervous system (CNS) and the gastrointestinal tract. Digestive products of the gut microbiome, microorganisms that colonize the gut, are able to influence brain function and its immune environment as circulating factors that can cross the blood-brain barrier. Particularly, short-chain fatty acids (SCFAs) have been linked to the activation of microglia, immune cells present in the brain. The role of these factors in GBM tumour initiation remains unknown, but the prevalence of inflammation in GBM implicates their potential for promoting tumour progression through immune cell populations. The first aim of this project is to define the effects of the gut microbiome on GBM tumour initiation using mouse models. Subsequently, we will interrogate the effect of specific factors produced by the gut microbiome, such as SCFAs, on human GBM stem cell cultures to determine their influence on driving cancer formation. As GBM research is largely focused on factors of the CNS, we are aiming to provide a fresh perspective on brain cancer biology by studying the GBA. Ascertaining the link between the gut and brain tumour development will open up new avenues for therapeutic interventions that target the gut microbiome.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Liao, Kaixi C
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~